Bristol Myers to acquire cell therapy partner 2seventy bio in $286M all-cash deal Bristol Myers to acquire cell therapy partner 2seventy bio in $286M all-cash deal Post Contentbmy, tsvtRead More You might also be interested in reading Ripple Secures New Licenses in New York and Texas. March 11, 2025 In Mainstream ← Previous post Next post →